{"meta":{"query_hash":"8f0bd56e6dde","filters":{"venue":"Neurodegenerative Disease Management"},"cohort_total":43,"direct_labels_cover":0,"predictions_cover":43,"exported":43,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/8f0bd56e6dde","api":"https://metacan.xera.ac/api/v1/cohort?venue=Neurodegenerative+Disease+Management"},"results":[{"id":"W1967703150","doi":"10.2217/nmt.11.49","title":"Comparison of Exercise Strategies for Motor Symptom Improvement in Parkinson’s Disease","year":2011,"lang":"en","type":"article","venue":"Neurodegenerative Disease Management","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Wilfrid Laurier University","funders":"Parkinson Canada; Parkinson Society Canada","keywords":"Physical therapy; Physical medicine and rehabilitation; Parkinson's disease; Aerobic exercise; Rating scale; Medicine; Randomized controlled trial; Modalities; Psychology; Disease; Internal medicine","score_opus":0.04271817873463875,"score_gpt":0.3029107075431655,"score_spread":0.2601925288085268,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967703150","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99597067,0.0025437062,0.0001609729,0.000078960154,0.000059338243,0.00072596763,0.00006096926,0.000009854411,0.00038953248],"genre_scores_gemma":[0.994925,0.0018539091,0.0010447556,0.00009816882,0.00008382286,0.0014470447,0.00014706222,0.000002611514,0.0003976192],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9989722,0.00054641796,0.00015175722,0.00013251329,0.00011474809,0.00008244046],"domain_scores_gemma":[0.99884135,0.0005971587,0.00022625645,0.000046337158,0.0000713487,0.00021768334],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014798265,0.00075688603,0.0017507642,0.00062329444,0.00039840044,0.0004219498,0.00052856124,0.0009470463,0.0027714623],"category_scores_gemma":[0.0020566874,0.00038552316,0.00084895635,0.00023416754,0.00043739672,0.0003590069,0.00035807016,0.00066880597,0.00031695352],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7764942,0.080013,0.004479549,0.0033261124,0.0029363104,0.00006392616,0.00023190344,0.000757586,0.007852853,0.00010112393,0.00025694058,0.12348663],"study_design_scores_gemma":[0.34757906,0.6089975,0.037699845,0.00022858595,0.0013941925,0.00006820759,0.00010352284,0.00068151444,0.002262867,0.0001613845,0.00079539133,0.00002784165],"about_ca_topic_score_codex":0.00048570783,"about_ca_topic_score_gemma":0.0011056457,"teacher_disagreement_score":0.0027714623,"about_ca_system_score_codex":0.00040499,"about_ca_system_score_gemma":0.00044425332,"threshold_uncertainty_score":0.0092715025},"labels":[],"label_agreement":null},{"id":"W1974924861","doi":"10.2217/nmt.11.50","title":"Implications of a New Diagnostic Blood Test for Alzheimer’s Disease On Future Disease Management","year":2011,"lang":"en","type":"article","venue":"Neurodegenerative Disease Management","topic":"Alzheimer's disease research and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Montreal General Hospital","funders":"","keywords":"Disease; Dementia; Family history; Medicine; Population; Alzheimer's disease; Gerontology; Internal medicine","score_opus":0.05756196786905151,"score_gpt":0.3164721159376418,"score_spread":0.2589101480685903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974924861","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.027835114,0.041478768,0.011264688,0.85783756,0.027555542,0.00009425706,0.00045368823,0.00014448097,0.033335842],"genre_scores_gemma":[0.45772564,0.060961686,0.051278528,0.28891885,0.12416603,0.00027848428,0.00092610443,0.000109683235,0.01563487],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960324,0.0014432002,0.00058644,0.0004266584,0.0012485527,0.00026278017],"domain_scores_gemma":[0.9693391,0.018252771,0.0013592624,0.0009158574,0.0074539715,0.0026790544],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00913131,0.00070594426,0.0013936171,0.0012791443,0.0012343733,0.0029230968,0.0014313816,0.00849444,0.008308071],"category_scores_gemma":[0.03174806,0.0002931237,0.0012934802,0.0007580749,0.0018575258,0.004445053,0.0006575158,0.0056965975,0.0014523794],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033460804,0.0023437429,0.086269274,0.0009280018,0.00037643212,0.008494467,0.0004116171,0.0021745844,0.0045608706,0.062820286,0.18781124,0.64046335],"study_design_scores_gemma":[0.0021822522,0.005639484,0.093305305,0.004114461,0.0020906806,0.022286339,0.002022196,0.011088089,0.0061979634,0.19932944,0.6512704,0.00047335957],"about_ca_topic_score_codex":0.0050298884,"about_ca_topic_score_gemma":0.0063320505,"teacher_disagreement_score":0.00913131,"about_ca_system_score_codex":0.0022159459,"about_ca_system_score_gemma":0.0064503723,"threshold_uncertainty_score":0.048291564},"labels":[],"label_agreement":null},{"id":"W1980468738","doi":"10.2217/nmt.13.72","title":"Integrating Community Services into Primary Care: Improving the Quality of Dementia Care","year":2014,"lang":"en","type":"article","venue":"Neurodegenerative Disease Management","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alzheimer Society of Canada; St Joseph's Health Care; Lawson Health Research Institute; Centre for Family Medicine","funders":"","keywords":"General partnership; Dementia; Primary care; Nursing; Medicine; Quality (philosophy); Health care; Business; Public relations; Family medicine; Political science; Disease","score_opus":0.016965621901300094,"score_gpt":0.3077852713810352,"score_spread":0.2908196494797351,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980468738","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7020282,0.043637335,0.008793937,0.18195803,0.0027349947,0.0018919723,0.00030037368,0.00041100368,0.05824408],"genre_scores_gemma":[0.9753229,0.0073758154,0.009016003,0.0063867164,0.000431455,0.0002757508,0.00009855761,0.000016778065,0.0010760146],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9861245,0.009346858,0.0004476902,0.0004326675,0.0023705454,0.0012778471],"domain_scores_gemma":[0.98543733,0.002672005,0.0019392457,0.0006866695,0.002388566,0.006876164],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012638985,0.00032354504,0.0004358923,0.0012356008,0.0033258246,0.005098686,0.0016134406,0.0016288069,0.0036106159],"category_scores_gemma":[0.024165006,0.00026491136,0.00044173523,0.0011495063,0.0014678423,0.0022124555,0.0068233474,0.0015425943,0.00033004506],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019084741,0.0018318006,0.12759429,0.0030536065,0.00018974094,0.0012871056,0.012856274,0.00074226595,0.0014097869,0.0034049118,0.021257043,0.8261823],"study_design_scores_gemma":[0.0005458661,0.0049220785,0.71698517,0.010099844,0.00033268178,0.002766674,0.06943068,0.002032781,0.0010637181,0.009230702,0.18245943,0.00013044305],"about_ca_topic_score_codex":0.032760013,"about_ca_topic_score_gemma":0.06449962,"teacher_disagreement_score":0.032760013,"about_ca_system_score_codex":0.0045910254,"about_ca_system_score_gemma":0.03017158,"threshold_uncertainty_score":0.06684214},"labels":[],"label_agreement":null},{"id":"W2006577381","doi":"10.2217/nmt.14.39","title":"Diagnosing Motoric Cognitive Risk Syndrome to Predict Progression to Dementia","year":2014,"lang":"en","type":"editorial","venue":"Neurodegenerative Disease Management","topic":"Balance, Gait, and Falls Prevention","field":"Health Professions","cited_by":44,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Dementia; Neurology; Cognition; Gerontology; Cognitive decline; Population; Medicine; Psychology; Disease; Montreal Cognitive Assessment; Psychiatry; Cognitive impairment; Internal medicine","score_opus":0.01382001842113447,"score_gpt":0.3470559544398969,"score_spread":0.33323593601876245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006577381","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007716566,0.015033092,0.000168567,0.027969096,0.9556254,0.000039787785,0.0001086407,0.000041089916,0.00093721424],"genre_scores_gemma":[0.00066159666,0.011619327,0.00024866764,0.021821931,0.9626425,0.00005982622,0.00005443895,0.00001856068,0.0028732794],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99526817,0.0010254495,0.0012517152,0.0005604753,0.0016848344,0.00020929554],"domain_scores_gemma":[0.9576233,0.023801018,0.001598584,0.00061677856,0.0141522465,0.0022081402],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011030933,0.003623057,0.0055694496,0.004752258,0.002447039,0.0054535843,0.0038925074,0.019036736,0.0043188217],"category_scores_gemma":[0.044453423,0.0014687609,0.0039522843,0.002006564,0.0021037154,0.002951427,0.0010277432,0.025317693,0.005037688],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001221759,0.000051731047,0.0002129991,0.0007376414,0.00014461034,0.00016680412,0.00002014602,0.00003810707,0.000056087316,0.00021486568,0.9815969,0.016638026],"study_design_scores_gemma":[0.001124084,0.00029750424,0.0068400535,0.007723193,0.0021479444,0.0014593351,0.00023043081,0.0011437081,0.00041809358,0.00236529,0.9761077,0.00014270682],"about_ca_topic_score_codex":0.005261421,"about_ca_topic_score_gemma":0.009486623,"teacher_disagreement_score":0.019036736,"about_ca_system_score_codex":0.0023282599,"about_ca_system_score_gemma":0.0041746586,"threshold_uncertainty_score":0.058337808},"labels":[],"label_agreement":null},{"id":"W2036362473","doi":"10.2217/nmt.12.63","title":"The Health and well-being of Alzheimer’s Patients Requires an Integration of Services Centered On the Patient","year":2013,"lang":"en","type":"article","venue":"Neurodegenerative Disease Management","topic":"Interprofessional Education and Collaboration","field":"Health Professions","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Psychology; Medicine","score_opus":0.031034936652022428,"score_gpt":0.36714771574522653,"score_spread":0.3361127790932041,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036362473","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.33168143,0.039472736,0.029173,0.43453076,0.00416409,0.00071425637,0.00014224755,0.0006302389,0.15949115],"genre_scores_gemma":[0.83453286,0.030851545,0.06159785,0.05758601,0.0042329505,0.00058060786,0.00020509434,0.000091535905,0.010321524],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99419594,0.002506362,0.00037724565,0.00033941117,0.0014166674,0.0011644389],"domain_scores_gemma":[0.9834027,0.0039608506,0.0013124995,0.00052675285,0.0015888744,0.009208333],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005832076,0.00050307636,0.0008234223,0.0012453094,0.004949301,0.0074847457,0.0015391506,0.0038301323,0.0045639817],"category_scores_gemma":[0.011773809,0.0003402556,0.00080307096,0.00073487184,0.0029462634,0.0037517583,0.01000567,0.0049268804,0.0013074527],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019254826,0.0070546926,0.06329293,0.0017321563,0.00045328037,0.0023596648,0.022501219,0.001230339,0.004222615,0.019273885,0.056845125,0.8208416],"study_design_scores_gemma":[0.00043715333,0.0044332687,0.26827028,0.00827917,0.00041818456,0.013068995,0.12542883,0.002622011,0.002705005,0.17932968,0.39450812,0.0004993381],"about_ca_topic_score_codex":0.0035254466,"about_ca_topic_score_gemma":0.008391381,"teacher_disagreement_score":0.0074847457,"about_ca_system_score_codex":0.002504074,"about_ca_system_score_gemma":0.019094782,"threshold_uncertainty_score":0.030843318},"labels":[],"label_agreement":null},{"id":"W2047333481","doi":"10.2217/nmt.13.38","title":"Easing the Strain of Movement Disorders: From Translational and Clinical Science to Rehabilitation Strategies","year":2013,"lang":"en","type":"article","venue":"Neurodegenerative Disease Management","topic":"Stroke Rehabilitation and Recovery","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Wilfrid Laurier University","funders":"","keywords":"Medal; Globe; Political science; Library science; Management; Media studies; Gerontology; Medicine; History; Sociology; Art history; Ophthalmology","score_opus":0.016807636923137297,"score_gpt":0.31425134537156146,"score_spread":0.29744370844842416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047333481","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016976912,0.2573798,0.004511669,0.7167223,0.0050508757,0.00006978049,0.00003199867,0.000115796756,0.014420195],"genre_scores_gemma":[0.10517402,0.6624981,0.01761007,0.1839689,0.024122665,0.0005754222,0.00016307717,0.00013309933,0.00575465],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9898863,0.005017494,0.0007983026,0.00068844605,0.00262794,0.0009815773],"domain_scores_gemma":[0.9644576,0.021519259,0.0013803514,0.0015859922,0.00386756,0.0071892957],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03581894,0.0014852993,0.0022403905,0.0047222897,0.0028128966,0.012540078,0.0027556038,0.007815619,0.006561498],"category_scores_gemma":[0.03338476,0.0006391546,0.0009764908,0.002152655,0.020590555,0.016556896,0.010930573,0.013585595,0.0018798556],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002259337,0.0006356589,0.0023092185,0.0039739576,0.00015022926,0.00049277116,0.004646282,0.0005741881,0.00040613514,0.12695548,0.21799809,0.641632],"study_design_scores_gemma":[0.0002852318,0.00090293767,0.004630255,0.018760677,0.00010121854,0.0012693283,0.014091625,0.0008024938,0.0003979302,0.4770525,0.48153126,0.000174568],"about_ca_topic_score_codex":0.0037946287,"about_ca_topic_score_gemma":0.007421509,"teacher_disagreement_score":0.03581894,"about_ca_system_score_codex":0.007663248,"about_ca_system_score_gemma":0.026604367,"threshold_uncertainty_score":0.18943089},"labels":[],"label_agreement":null},{"id":"W2055299888","doi":"10.2217/nmt.12.37","title":"Management of Alzheimer’s Disease Using disease-modifying Drugs","year":2012,"lang":"en","type":"article","venue":"Neurodegenerative Disease Management","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Disease; Intensive care medicine; Medicine; Clinical Practice; Alzheimer's disease; Pathology; Family medicine","score_opus":0.05306711913838356,"score_gpt":0.34826797421715244,"score_spread":0.29520085507876886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055299888","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.082185164,0.78206974,0.0080395555,0.084370956,0.003988332,0.0002684497,0.00019098833,0.00025854967,0.038628366],"genre_scores_gemma":[0.41727853,0.5285748,0.015761076,0.021692691,0.00856027,0.00025927645,0.00031067763,0.000029948182,0.0075326962],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994685,0.0001568435,0.000108797736,0.000035575675,0.00018604482,0.00004427862],"domain_scores_gemma":[0.99910176,0.00024966858,0.00024031514,0.000033764423,0.00024233974,0.00013210875],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015960612,0.00025914764,0.000787155,0.00057097786,0.00038471195,0.0006270993,0.00059049734,0.0007265197,0.00130704],"category_scores_gemma":[0.0018096105,0.00005643181,0.00040659696,0.00023304162,0.00026287616,0.0006745546,0.0003779017,0.0013107312,0.00042677825],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051686214,0.00082660414,0.009059932,0.0031755543,0.00023983464,0.0019529246,0.00022182199,0.00030746017,0.0073156985,0.004054687,0.029476333,0.94285244],"study_design_scores_gemma":[0.0012633752,0.010129842,0.062436197,0.007539742,0.001287534,0.019277252,0.00081364095,0.0013508355,0.012564098,0.02379974,0.859432,0.000105800056],"about_ca_topic_score_codex":0.00042967434,"about_ca_topic_score_gemma":0.001049865,"teacher_disagreement_score":0.0015960612,"about_ca_system_score_codex":0.00037111645,"about_ca_system_score_gemma":0.000705168,"threshold_uncertainty_score":0.008440912},"labels":[],"label_agreement":null},{"id":"W2113866317","doi":"10.2217/nmt.11.14","title":"Managing relapsing–remitting Multiple Sclerosis Following First Drug Failure","year":2011,"lang":"en","type":"article","venue":"Neurodegenerative Disease Management","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital; Health Sciences Centre","funders":"","keywords":"Glatiramer acetate; Multiple sclerosis; Relapsing remitting; Medicine; Intensive care medicine; Disease; Drug; First line; Immunology; Pharmacology; Internal medicine","score_opus":0.07019769101573509,"score_gpt":0.26761695616411535,"score_spread":0.19741926514838026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2113866317","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85969394,0.10548914,0.0025556684,0.016976388,0.0010610392,0.0006996477,0.00016684315,0.00008043409,0.013276986],"genre_scores_gemma":[0.97403616,0.01766432,0.002469629,0.0028674726,0.0012113407,0.0002720053,0.00013097939,0.000009585011,0.0013385167],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99843305,0.00088250363,0.00019374941,0.00010107562,0.00017959198,0.00021000755],"domain_scores_gemma":[0.99311125,0.0031466442,0.0018023757,0.00022949209,0.00066959765,0.0010406905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005428635,0.00029516866,0.0017545318,0.0009984481,0.0011021517,0.00089512806,0.000488524,0.0011879207,0.0017685976],"category_scores_gemma":[0.010075789,0.00014632911,0.00054963527,0.00048812485,0.0004639498,0.000941446,0.0008309084,0.0014529251,0.00051317055],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006504596,0.0024901845,0.16996065,0.0034253006,0.00064881094,0.045723025,0.004757888,0.0010618445,0.0066786935,0.001632933,0.020491902,0.7366243],"study_design_scores_gemma":[0.0057746163,0.08391767,0.5063645,0.011955388,0.002723897,0.13848948,0.0144217,0.0035486277,0.023064218,0.016834896,0.19251467,0.00039036767],"about_ca_topic_score_codex":0.0009025193,"about_ca_topic_score_gemma":0.0013037781,"teacher_disagreement_score":0.005428635,"about_ca_system_score_codex":0.0007107642,"about_ca_system_score_gemma":0.0009791179,"threshold_uncertainty_score":0.02870977},"labels":[],"label_agreement":null},{"id":"W2114005972","doi":"10.2217/nmt.13.6","title":"Neuropsychiatric Symptoms in Primary Progressive Aphasia: phenomenology, pathophysiology, and Approach to Assessment and Treatment","year":2013,"lang":"en","type":"article","venue":"Neurodegenerative Disease Management","topic":"Neurobiology of Language and Bilingualism","field":"Neuroscience","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"National Institute of Neurological Disorders and Stroke; National Institute on Aging; National Institutes of Health; Sidney R. Baer, Jr. Foundation","keywords":"Primary progressive aphasia; Phenomenology (philosophy); Pathophysiology; Aphasia; Psychology; Psychotherapist; Primary (astronomy); Medicine; Neuroscience; Disease; Philosophy; Dementia; Pathology; Epistemology; Physics","score_opus":0.015320660129572847,"score_gpt":0.26902449453877125,"score_spread":0.2537038344091984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114005972","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.18593885,0.7217899,0.013867626,0.026629863,0.0009764758,0.0006766282,0.00024361126,0.00027312426,0.04960396],"genre_scores_gemma":[0.69035155,0.2823337,0.01609628,0.0043794867,0.0022860372,0.00050769927,0.00021446617,0.000031082644,0.0037996804],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997482,0.000080498576,0.00006602576,0.000021971098,0.000052813706,0.000030566374],"domain_scores_gemma":[0.9997631,0.0000879829,0.000049931135,0.0000073388446,0.00004973927,0.00004195915],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007119651,0.0008043438,0.0009266858,0.0010703278,0.0005268729,0.000828591,0.0005913475,0.0012041642,0.00056156196],"category_scores_gemma":[0.0014345461,0.00016827896,0.00036193235,0.00044831348,0.0006505942,0.00077658676,0.0007090535,0.0016246351,0.00024061649],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007418794,0.0011507056,0.09341608,0.005068757,0.00020083031,0.098953106,0.0022001124,0.0019538112,0.012967772,0.0069570835,0.01214981,0.76424],"study_design_scores_gemma":[0.00062067,0.0027984688,0.28124246,0.007873172,0.00044680847,0.598534,0.0069028013,0.0048310063,0.0051887096,0.021989483,0.06927696,0.00029551814],"about_ca_topic_score_codex":0.0016176861,"about_ca_topic_score_gemma":0.0027466828,"teacher_disagreement_score":0.0016176861,"about_ca_system_score_codex":0.0009991517,"about_ca_system_score_gemma":0.0013004235,"threshold_uncertainty_score":0.007249415},"labels":[],"label_agreement":null},{"id":"W2118999156","doi":"10.2217/nmt.12.66","title":"‘Throwing a lifeline‘: the Role of First Link™ in Enhancing Support for Individuals With Dementia and Their Caregivers","year":2012,"lang":"en","type":"article","venue":"Neurodegenerative Disease Management","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alzheimer Society of Canada; St Joseph's Health Care; University of Waterloo; Lawson Health Research Institute; McMaster University; St. Joseph’s Healthcare Hamilton","funders":"Ontario Ministry of Health and Long-Term Care; Alzheimer Society","keywords":"Dementia; Throwing; Link (geometry); Psychology; Medicine; Computer science; Engineering; Aeronautics; Disease; Computer network","score_opus":0.011537276199093404,"score_gpt":0.26428187841915346,"score_spread":0.25274460222006007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118999156","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9386165,0.0045272945,0.0011913507,0.032182105,0.00028309098,0.00046001174,0.00010050129,0.000096785174,0.022542294],"genre_scores_gemma":[0.98617953,0.002386048,0.0057170885,0.0028131774,0.000055668304,0.00033616897,0.000076502976,0.000009216029,0.0024265517],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99755055,0.0013513624,0.00007620539,0.00010549765,0.00036825667,0.00054814125],"domain_scores_gemma":[0.9912894,0.0014679458,0.00090727344,0.00026791418,0.0011911244,0.004876303],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00560002,0.00025731805,0.0003074416,0.00061478827,0.0034226875,0.0019567152,0.001867797,0.00074673357,0.0030617658],"category_scores_gemma":[0.010458422,0.00022070587,0.00030141242,0.00050971785,0.001666499,0.0013619914,0.0037767356,0.001269922,0.00027668526],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005277022,0.002824484,0.10724197,0.0017301013,0.00010601879,0.0005817967,0.08476196,0.0002436667,0.0008766987,0.0016111945,0.03901121,0.7604832],"study_design_scores_gemma":[0.0006473239,0.005440749,0.518914,0.005846816,0.000417256,0.0013543057,0.25465715,0.0012080417,0.0022302403,0.0033751014,0.20565303,0.00025600364],"about_ca_topic_score_codex":0.0874033,"about_ca_topic_score_gemma":0.28381774,"teacher_disagreement_score":0.0874033,"about_ca_system_score_codex":0.007703892,"about_ca_system_score_gemma":0.025516354,"threshold_uncertainty_score":0.17378908},"labels":[],"label_agreement":null},{"id":"W2126966802","doi":"10.2217/nmt.13.32","title":"Evidence-based Advances in the Treatment of Motor Features of Parkinson's Disease","year":2013,"lang":"en","type":"article","venue":"Neurodegenerative Disease Management","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Dyskinesia; Intensive care medicine; Evidence-based medicine; Levodopa; Scientific evidence; Narcolepsy; Disease; Modafinil; Psychiatry; Parkinson's disease; Physical medicine and rehabilitation; Alternative medicine; Internal medicine","score_opus":0.028606913831032393,"score_gpt":0.2821197656993208,"score_spread":0.2535128518682884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126966802","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00033019067,0.9874785,0.0003609222,0.007998074,0.00071665365,0.000025415064,0.00008020389,0.0000128710835,0.0029971637],"genre_scores_gemma":[0.008974701,0.9847429,0.0023472223,0.002256402,0.0011306249,0.000035579233,0.00011963312,0.0000050020276,0.00038795377],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9932765,0.0029022666,0.0015085608,0.00026136645,0.0018394181,0.00021190762],"domain_scores_gemma":[0.98102564,0.012242072,0.0028632688,0.00041986877,0.0028964372,0.0005527246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0117973,0.00085115473,0.0021565782,0.0038794703,0.0003552396,0.002699476,0.0016775461,0.002393872,0.008130144],"category_scores_gemma":[0.022343658,0.00030518885,0.002133369,0.002719781,0.0006674127,0.0018426619,0.001267854,0.0031903822,0.0014261982],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005685387,0.00020450688,0.0010319666,0.07280928,0.0017830734,0.00037393556,0.000121433775,0.0006848546,0.00048862543,0.007077481,0.04023226,0.874624],"study_design_scores_gemma":[0.0007663154,0.0011821232,0.010767323,0.31759316,0.007711019,0.0017491146,0.0003430374,0.0005652509,0.00090027176,0.023258315,0.63506895,0.000095167976],"about_ca_topic_score_codex":0.0022003108,"about_ca_topic_score_gemma":0.0050761127,"teacher_disagreement_score":0.0117973,"about_ca_system_score_codex":0.0019714048,"about_ca_system_score_gemma":0.0041584647,"threshold_uncertainty_score":0.062390804},"labels":[],"label_agreement":null},{"id":"W2129350985","doi":"10.2217/nmt.11.23","title":"ABCA1, Apoe and apoA-I As Potential Therapeutic Targets for Treating Alzheimer’s Disease","year":2011,"lang":"en","type":"article","venue":"Neurodegenerative Disease Management","topic":"Cholesterol and Lipid Metabolism","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Apolipoprotein E; ABCA1; Disease; Neuroprotection; Neuroscience; Transporter; Alzheimer's disease; Cholesterol; Pathogenesis; Medicine; Biology; Bioinformatics; Pharmacology; Immunology; Internal medicine; Genetics; Gene","score_opus":0.03952721411576197,"score_gpt":0.2810018794374431,"score_spread":0.24147466532168113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129350985","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.05389167,0.90607226,0.002965105,0.02066391,0.0015729129,0.000063452375,0.0001348547,0.000104619074,0.014531329],"genre_scores_gemma":[0.26340693,0.7078406,0.0057600616,0.004217263,0.0029603352,0.00013336871,0.00021888857,0.000020543479,0.015441948],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999217,0.000025319228,0.0000074612667,0.000006796781,0.000020340847,0.00001834949],"domain_scores_gemma":[0.9998988,0.000030674448,0.000017005645,0.000003640366,0.000029005476,0.000020924863],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045541357,0.00026295762,0.00048491152,0.0004535338,0.00013805648,0.0006269209,0.00024122452,0.0006469801,0.0034033775],"category_scores_gemma":[0.00028211798,0.00007064385,0.00021683579,0.00026951512,0.00032350834,0.0005346373,0.00026909405,0.0008650561,0.00069527584],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018645913,0.00069280644,0.0023854275,0.0029165095,0.000133655,0.0016590297,0.00016750797,0.0009632934,0.049781684,0.016866196,0.044488683,0.8780806],"study_design_scores_gemma":[0.0014120506,0.005504824,0.010442197,0.0013348953,0.0005519133,0.006973219,0.0004302568,0.0026761573,0.04293338,0.01788124,0.909789,0.00007079715],"about_ca_topic_score_codex":0.00043047074,"about_ca_topic_score_gemma":0.0011465504,"teacher_disagreement_score":0.0034033775,"about_ca_system_score_codex":0.00028233055,"about_ca_system_score_gemma":0.0003505771,"threshold_uncertainty_score":0.011385381},"labels":[],"label_agreement":null},{"id":"W2133551071","doi":"10.2217/nmt.14.5","title":"Depression Versus Dementia: Is This Construct Still relevant?","year":2014,"lang":"en","type":"review","venue":"Neurodegenerative Disease Management","topic":"Tryptophan and brain disorders","field":"Neuroscience","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotchkiss Brain Institute; Ontario Brain Institute; University of Toronto; St. Michael's Hospital; University of Calgary","funders":"","keywords":"Dementia; Prodrome; Depression (economics); Cognitive decline; Cognition; Late life depression; Cognitive impairment; Psychology; Etiology; Population; Clinical psychology; Psychiatry; Medicine; Neurodegeneration; Disease; Internal medicine","score_opus":0.050342392182383476,"score_gpt":0.31858143763878555,"score_spread":0.2682390454564021,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2133551071","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009566267,0.9974457,0.00006191283,0.0014579181,0.00036954758,0.0000018662461,0.0000067724936,0.0000020648165,0.0005585107],"genre_scores_gemma":[0.0012985717,0.9967451,0.000108266446,0.00094681326,0.0005332968,0.0000044532258,0.00001225681,0.0000012831025,0.0003499568],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99967587,0.00011230783,0.000059966213,0.000049845523,0.00007327949,0.000028782257],"domain_scores_gemma":[0.9991974,0.00052691996,0.000078394914,0.00001675524,0.00013569099,0.000044916174],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009375142,0.00058803963,0.0017801234,0.0013945809,0.00039499,0.0018478647,0.0009247318,0.0021287075,0.0022310014],"category_scores_gemma":[0.0019685454,0.00021874913,0.00056240347,0.0018561657,0.0016675863,0.0026881658,0.0010111699,0.0027075296,0.0010475632],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001360162,0.000041892115,0.00057782105,0.0227521,0.00017073337,0.0005091816,0.00041796107,0.00013182072,0.00062576815,0.017820925,0.044161428,0.9126543],"study_design_scores_gemma":[0.00003780116,0.00013292147,0.0029909057,0.02609788,0.0002595328,0.006298308,0.0011587128,0.00014917579,0.00026500245,0.021392537,0.94117755,0.000039670853],"about_ca_topic_score_codex":0.002328993,"about_ca_topic_score_gemma":0.003265524,"teacher_disagreement_score":0.002328993,"about_ca_system_score_codex":0.001128711,"about_ca_system_score_gemma":0.002098665,"threshold_uncertainty_score":0.00818944},"labels":[],"label_agreement":null},{"id":"W2406736647","doi":"10.2217/nmt-2016-0005","title":"Nondopaminergic Treatments for Parkinson’s Disease: Current and Future Prospects","year":2016,"lang":"en","type":"review","venue":"Neurodegenerative Disease Management","topic":"Neurological disorders and treatments","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto Western Hospital","funders":"","keywords":"Pharmacology; Dyskinesia; Dopaminergic; Levodopa; Medicine; Parkinson's disease; Antagonist; Monoamine oxidase; Dopamine; Neuroscience; Disease; Receptor; Chemistry; Psychology; Internal medicine; Biochemistry; Enzyme","score_opus":0.03581807469957903,"score_gpt":0.3291868301148216,"score_spread":0.29336875541524254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2406736647","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000080970356,0.9989967,0.00004802966,0.0002531916,0.00009545536,0.0000033545152,0.00001576941,0.000004751228,0.0005017826],"genre_scores_gemma":[0.0003525947,0.99899465,0.00012502981,0.00014680669,0.00010068345,0.000003737955,0.000020135536,9.0323e-7,0.00025558894],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99983346,0.00003060419,0.000035949124,0.000029350782,0.00005372991,0.000016746155],"domain_scores_gemma":[0.9995523,0.00022167066,0.00007279591,0.000009806244,0.00011035412,0.00003307818],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005743866,0.00074775144,0.001318889,0.0020147325,0.00026808382,0.0009072622,0.00073204946,0.0010466096,0.007613006],"category_scores_gemma":[0.0006938041,0.00022198944,0.0007322256,0.001731294,0.00033393202,0.0013698682,0.00058579055,0.0016251303,0.002143495],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000106965956,0.00011105159,0.00014347014,0.0260425,0.00009105925,0.0001605293,0.000048562015,0.00016715775,0.00097010727,0.0015737095,0.020185549,0.9503994],"study_design_scores_gemma":[0.00004544092,0.00020060968,0.0010741643,0.01357878,0.00035870378,0.0015030382,0.000110861074,0.00011590186,0.00035414763,0.002394598,0.9802388,0.000025006515],"about_ca_topic_score_codex":0.0008758995,"about_ca_topic_score_gemma":0.0027192612,"teacher_disagreement_score":0.007613006,"about_ca_system_score_codex":0.00042175862,"about_ca_system_score_gemma":0.0009162609,"threshold_uncertainty_score":0.025468051},"labels":[],"label_agreement":null},{"id":"W2518401648","doi":"10.2217/nmt-2016-0028","title":"Elucidating the Link Between the Modifiable Risk Factors of Alzheimer’s Disease and Neuroinflammation","year":2016,"lang":"en","type":"article","venue":"Neurodegenerative Disease Management","topic":"Neuroinflammation and Neurodegeneration Mechanisms","field":"Neuroscience","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Okanagan University College; University of British Columbia, Okanagan Campus; University of British Columbia","funders":"","keywords":"Neuroinflammation; Microglia; Disease; Medicine; Alzheimer's disease; Diabetes mellitus; Neuroscience; Immune system; Risk factor; Immunology; Psychology; Inflammation; Internal medicine; Endocrinology","score_opus":0.046299871767104685,"score_gpt":0.26424517864353203,"score_spread":0.21794530687642735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2518401648","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7988765,0.17973217,0.0077170306,0.005156247,0.00027898155,0.000057642294,0.0004216129,0.00004573748,0.00771402],"genre_scores_gemma":[0.88276845,0.106362276,0.00749882,0.0006998673,0.0004309036,0.000048157308,0.00020515955,0.000007226556,0.0019790202],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.99990773,0.000024051347,0.000009774775,0.000021433654,0.00002097984,0.000015978469],"domain_scores_gemma":[0.9997924,0.000041793963,0.00010566982,0.000013525735,0.00002483255,0.000021734613],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033268862,0.00043516155,0.0004161611,0.0005115304,0.00024410384,0.0006805083,0.00022665122,0.00044034072,0.0013865596],"category_scores_gemma":[0.0004133764,0.000097988705,0.00023688175,0.00031441668,0.00029773838,0.0004598888,0.00035405104,0.0005990409,0.00019007537],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026473252,0.0014609911,0.30452698,0.0031379987,0.001064606,0.0035490424,0.0012395014,0.0010358744,0.27018774,0.016519614,0.0043699574,0.39026034],"study_design_scores_gemma":[0.00008505659,0.0017690194,0.8480552,0.0009640358,0.0010902204,0.0058188057,0.0009768265,0.0018686334,0.06576318,0.030410625,0.04312754,0.00007097695],"about_ca_topic_score_codex":0.0008250751,"about_ca_topic_score_gemma":0.0017301382,"teacher_disagreement_score":0.0013865596,"about_ca_system_score_codex":0.00029010331,"about_ca_system_score_gemma":0.0004984297,"threshold_uncertainty_score":0.004638493},"labels":[],"label_agreement":null},{"id":"W2752267739","doi":"10.2217/nmt-2017-0015","title":"Health System Redesign Using Collective Impact: Implementation of the Behavioural Supports Ontario Initiative in Southwest Ontario","year":2017,"lang":"en","type":"article","venue":"Neurodegenerative Disease Management","topic":"Health Policy Implementation Science","field":"Health Professions","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ontario Stroke Network; Hamilton Health Sciences; St Joseph's Health Care; Lawson Health Research Institute","funders":"","keywords":"Neurocognitive; Process management; Mental health; Scale (ratio); Business; Healthcare system; Collective leadership; Theory of change; Public relations; Service (business); Nursing; Health care; Psychology; Knowledge management; Political science; Medicine; Cognition; Marketing; Computer science; Sociology; Psychiatry; Geography","score_opus":0.422591144028049,"score_gpt":0.5633648945292784,"score_spread":0.14077375050122942,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2752267739","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8796783,0.0015369573,0.007586349,0.05630504,0.00025591123,0.004110997,0.0006935695,0.00023505201,0.049597885],"genre_scores_gemma":[0.9765618,0.0009359157,0.010323699,0.002063167,0.000055755994,0.0011674727,0.00037556546,0.0000356624,0.00848091],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9821035,0.0073240036,0.0007735446,0.00072405743,0.00454472,0.0045301197],"domain_scores_gemma":[0.97913194,0.0030802377,0.0018760313,0.0011164959,0.006344429,0.008450906],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02185821,0.00047563255,0.00038002236,0.0013241784,0.011176819,0.003612402,0.0022283462,0.001178118,0.0023128584],"category_scores_gemma":[0.018853698,0.00042798114,0.0005953546,0.0022377935,0.004652316,0.0016479008,0.007742964,0.0014277705,0.00018628525],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009157934,0.0020410938,0.23902519,0.0021025436,0.00030705892,0.002028367,0.21591431,0.0077335685,0.0038297013,0.023628095,0.031524323,0.47094998],"study_design_scores_gemma":[0.00072786014,0.003365681,0.5589276,0.0009817142,0.00024340893,0.00020673349,0.2058634,0.0049035097,0.0024028963,0.005577989,0.21661586,0.000183317],"about_ca_topic_score_codex":0.94137365,"about_ca_topic_score_gemma":0.9737507,"teacher_disagreement_score":0.13853878,"about_ca_system_score_codex":0.13853878,"about_ca_system_score_gemma":0.38398638,"threshold_uncertainty_score":0.9991729},"labels":[],"label_agreement":null},{"id":"W2752322426","doi":"10.2217/nmt-2017-0014","title":"Treatment Gaps in Parkinson’s Disease Care in the Philippines","year":2017,"lang":"en","type":"review","venue":"Neurodegenerative Disease Management","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Movement Disorders; University of Alberta","funders":"","keywords":"Health care; Medicine; Government (linguistics); Disease; Developing country; Population; Epidemiology; Business; Economic growth; Environmental health; Economics","score_opus":0.07223312978937874,"score_gpt":0.35843260161348933,"score_spread":0.2861994718241106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2752322426","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012763057,0.99910307,0.000017785142,0.00039207173,0.00004854133,0.0000030551498,0.000014400827,0.000002473447,0.00029092317],"genre_scores_gemma":[0.0016713445,0.9978381,0.00009324015,0.00020663203,0.00006198293,0.000005590809,0.000026500658,8.7335195e-7,0.00009587551],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993795,0.00017354185,0.00014891106,0.000068191664,0.00018059302,0.000049162965],"domain_scores_gemma":[0.9986739,0.0005962287,0.00026288923,0.00002099788,0.00036207307,0.00008395172],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001552439,0.0005794499,0.0013189669,0.0029001532,0.0004054381,0.0013300843,0.0009885413,0.0010332917,0.0037428183],"category_scores_gemma":[0.002631097,0.00025583222,0.0007681597,0.0029166986,0.000444063,0.0015475457,0.0010170669,0.0011789955,0.0005713394],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000066146495,0.000065065244,0.0008972121,0.06592949,0.00020947725,0.00030396902,0.00034594582,0.0002438045,0.00026760655,0.0019799178,0.02108119,0.9086103],"study_design_scores_gemma":[0.000041494546,0.0001824942,0.0059149666,0.07379352,0.00081319973,0.0026172542,0.0009145775,0.00022752871,0.00032782607,0.0022810558,0.9128485,0.000037652837],"about_ca_topic_score_codex":0.0062326347,"about_ca_topic_score_gemma":0.012157519,"teacher_disagreement_score":0.0062326347,"about_ca_system_score_codex":0.0013403568,"about_ca_system_score_gemma":0.0046149925,"threshold_uncertainty_score":0.012520969},"labels":[],"label_agreement":null},{"id":"W2782023683","doi":"10.2217/nmt-2017-0054","title":"Advancing the Understanding of Progression in Multiple Sclerosis: An Interview With Shibeshih Belachew","year":2018,"lang":"en","type":"article","venue":"Neurodegenerative Disease Management","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Center for Neuroscience Research; National Institutes of Health; Children's National Hospital; Biogen","keywords":"Library science; Clinical neurology; Medicine; Medical education; Family medicine; Management; Psychology; Neuroscience","score_opus":0.1548569299515765,"score_gpt":0.3465572736736507,"score_spread":0.1917003437220742,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2782023683","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018427809,0.034856707,0.00046832918,0.94523895,0.015972778,0.00003368007,0.000028135224,0.000023847651,0.0015347869],"genre_scores_gemma":[0.03820881,0.07381435,0.0024641773,0.8422895,0.03403074,0.00028649377,0.000067495894,0.00011328482,0.008725177],"study_design_codex":"not_applicable","study_design_gemma":"qualitative","domain_scores_codex":[0.9921731,0.005060656,0.00039997802,0.00053071824,0.0012358377,0.000599645],"domain_scores_gemma":[0.97558355,0.014511883,0.00091447646,0.00026700296,0.0034429186,0.0052801967],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01734981,0.00080118526,0.00201751,0.0012457281,0.0052472106,0.0050230487,0.0018827629,0.0070644272,0.0020276515],"category_scores_gemma":[0.031638425,0.0009240153,0.00086698163,0.0012356085,0.0069829,0.011603856,0.0032960782,0.032007817,0.0009062556],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000060048606,0.00010381071,0.0010493372,0.00033134315,0.000025361276,0.0011088623,0.04386974,0.0000661491,0.00027204384,0.0041222735,0.9192824,0.029708618],"study_design_scores_gemma":[0.000089805624,0.00020667283,0.0029279825,0.0018377386,0.000033658456,0.006565528,0.07792157,0.00030163376,0.00018109877,0.008383292,0.9014011,0.00014996673],"about_ca_topic_score_codex":0.012118999,"about_ca_topic_score_gemma":0.014324091,"teacher_disagreement_score":0.01734981,"about_ca_system_score_codex":0.005580505,"about_ca_system_score_gemma":0.008445039,"threshold_uncertainty_score":0.09175569},"labels":[],"label_agreement":null},{"id":"W2901894875","doi":"10.2217/nmt-2018-0024","title":"Persons with Dementia and Care Partners’ Perspectives on Memory Clinics in Primary Care","year":2018,"lang":"en","type":"article","venue":"Neurodegenerative Disease Management","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Peter's Hospital; McMaster University; Centre for Family Medicine","funders":"","keywords":"Dementia; Primary care; Memory clinic; Psychology; Cognition; Nursing; Collaborative Care; Medicine; Cognitive impairment; Family medicine; Psychiatry; Disease","score_opus":0.01749310430209817,"score_gpt":0.3127171981982451,"score_spread":0.29522409389614696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2901894875","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97361404,0.0043871203,0.00041518893,0.010505082,0.00014274938,0.000053546082,0.000063118765,0.000013778735,0.010805363],"genre_scores_gemma":[0.99637777,0.0012067304,0.00020874984,0.0015745969,0.00004361486,0.00002606325,0.000017786953,0.0000031661943,0.00054160075],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.9911732,0.0067052823,0.00023245445,0.00025512846,0.000586688,0.0010472973],"domain_scores_gemma":[0.99328893,0.002671475,0.0010440372,0.00011838556,0.0005680778,0.0023091044],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0049054916,0.0002642439,0.0004427738,0.0005086959,0.0061034835,0.004543167,0.00083628675,0.0016513262,0.0029279804],"category_scores_gemma":[0.010672137,0.00036045516,0.0003953586,0.00054169295,0.0032403679,0.0023853227,0.0036242984,0.0019699682,0.00020325964],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016610297,0.00029638942,0.055757377,0.00044419125,0.000053320924,0.004435182,0.9014437,0.0001039774,0.0005827674,0.001437328,0.0054097963,0.029869836],"study_design_scores_gemma":[0.0000301857,0.00033741142,0.025078053,0.00047483933,0.000037648882,0.0031308255,0.95553255,0.00009904809,0.0001677229,0.0003497116,0.014734076,0.000027975097],"about_ca_topic_score_codex":0.016982237,"about_ca_topic_score_gemma":0.032244235,"teacher_disagreement_score":0.016982237,"about_ca_system_score_codex":0.0029757142,"about_ca_system_score_gemma":0.003521664,"threshold_uncertainty_score":0.033766747},"labels":[],"label_agreement":null},{"id":"W2910229208","doi":"10.2217/nmt-2018-0031","title":"Person-Centered Risk Assessment Framework: Assessing and Managing Risk in Older Adults Living With Dementia","year":2019,"lang":"en","type":"article","venue":"Neurodegenerative Disease Management","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Peter's Hospital; McMaster University; Centre for Family Medicine","funders":"","keywords":"Dementia; Risk assessment; Health care; Nursing; Medicine; Psychology; Disease","score_opus":0.01243781710770302,"score_gpt":0.2893636226231173,"score_spread":0.2769258055154143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2910229208","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.67371356,0.008478986,0.2356957,0.02905575,0.0006444741,0.010340232,0.0013755613,0.001450461,0.03924523],"genre_scores_gemma":[0.6889932,0.0019330883,0.30327678,0.0015645395,0.00008368696,0.0025055595,0.00057604624,0.000029537545,0.0010376053],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.98167026,0.012861627,0.0014280111,0.00053271157,0.002871699,0.0006356386],"domain_scores_gemma":[0.97818315,0.010750572,0.0034299225,0.0010312352,0.0043434226,0.0022616915],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.029012084,0.00088890415,0.00080474705,0.0028926628,0.001865782,0.0029348473,0.0016345178,0.0012781827,0.0012496796],"category_scores_gemma":[0.038869493,0.00043616554,0.0024559607,0.00090328965,0.0012315941,0.0030228028,0.004578882,0.0024026667,0.00028785653],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043664995,0.0028393283,0.23981522,0.0031816806,0.0005915205,0.0006897508,0.06044691,0.003917522,0.001083632,0.011690173,0.014530371,0.6607772],"study_design_scores_gemma":[0.0011304248,0.011153839,0.50258815,0.018382926,0.0022221527,0.008487518,0.1417548,0.04982207,0.0045523066,0.08032607,0.17819922,0.0013804976],"about_ca_topic_score_codex":0.0073348405,"about_ca_topic_score_gemma":0.013935961,"teacher_disagreement_score":0.029012084,"about_ca_system_score_codex":0.0032985855,"about_ca_system_score_gemma":0.010875848,"threshold_uncertainty_score":0.15343243},"labels":[],"label_agreement":null},{"id":"W2978087496","doi":"10.2217/nmt-2019-0017","title":"What is Test Accuracy? Comparing Unitary Accuracy Metrics for Cognitive Screening Instruments","year":2019,"lang":"en","type":"article","venue":"Neurodegenerative Disease Management","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Receiver operating characteristic; Metric (unit); Dementia; Test (biology); Cognition; Cognitive impairment; Raw score; Statistics; Measure (data warehouse); Psychology; Computer science; Medicine; Mathematics; Data mining; Raw data; Psychiatry; Engineering","score_opus":0.04453971085852782,"score_gpt":0.3395502077307218,"score_spread":0.295010496872194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2978087496","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.82118464,0.025399663,0.1304727,0.0047352873,0.0010869707,0.0006127108,0.001819104,0.0010135049,0.0136754485],"genre_scores_gemma":[0.9857087,0.00060848147,0.012363313,0.0002923838,0.00017325347,0.00020617906,0.00037466013,0.00008532045,0.00018775323],"study_design_codex":"observational","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.8517581,0.090348095,0.017022403,0.0077474797,0.030666579,0.0024573877],"domain_scores_gemma":[0.3718499,0.5306541,0.040355995,0.026093611,0.029146042,0.0019004084],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.1465184,0.0012014637,0.0019306018,0.008784629,0.001010737,0.005789497,0.0021499558,0.0027995782,0.0009176562],"category_scores_gemma":[0.50566816,0.00051151577,0.0026712131,0.0058748634,0.0039410917,0.006496629,0.0029767107,0.0017499946,0.00040482654],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016495591,0.00013304282,0.8140257,0.0009899957,0.0030926892,0.00012681409,0.0024590893,0.004625597,0.0006044258,0.0067738206,0.0023909314,0.1631283],"study_design_scores_gemma":[0.00019990628,0.0050493516,0.8913215,0.0018081286,0.0021067054,0.0014275075,0.0028057399,0.049362753,0.006343612,0.031185132,0.008071008,0.00031864058],"about_ca_topic_score_codex":0.0025297296,"about_ca_topic_score_gemma":0.0029553627,"teacher_disagreement_score":0.8534816,"about_ca_system_score_codex":0.0023040068,"about_ca_system_score_gemma":0.0017101715,"threshold_uncertainty_score":0.7748726},"labels":[],"label_agreement":null},{"id":"W2978638447","doi":"10.2217/nmt-2019-0015","title":"Is Huntington’s Disease On the Threshold of a New Era in Treatment?","year":2019,"lang":"en","type":"editorial","venue":"Neurodegenerative Disease Management","topic":"Genetic Neurodegenerative Diseases","field":"Neuroscience","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"MEDLINE; Disease; Huntington's disease; Medicine; Family medicine; Library science; Psychiatry; Internal medicine; Biology; Computer science","score_opus":0.03609737167322812,"score_gpt":0.28901521388215906,"score_spread":0.25291784220893093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2978638447","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000023190152,0.01393843,0.00009136091,0.04363903,0.9411354,0.000010696263,0.000026188496,0.000025585523,0.0011101038],"genre_scores_gemma":[0.00026497705,0.007243462,0.000070990805,0.02320152,0.9659033,0.000012965822,0.000012853418,0.000012784079,0.0032772655],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9944149,0.0014408593,0.0008391931,0.000497668,0.0024260741,0.00038123195],"domain_scores_gemma":[0.969598,0.017197436,0.0016812952,0.0005763551,0.00716014,0.003786762],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010703463,0.0032328393,0.0047480445,0.0031835048,0.0029976405,0.007061869,0.0037738122,0.02189023,0.009562922],"category_scores_gemma":[0.03137482,0.0011399698,0.0023381605,0.0012443004,0.0033083775,0.0060089477,0.0017212541,0.027156886,0.0075715207],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006680297,0.000015230495,0.00002682494,0.0003999036,0.000026651263,0.00013426063,0.000013337563,0.00003177936,0.000040862175,0.00051944086,0.9906465,0.008078491],"study_design_scores_gemma":[0.00012952863,0.000061555824,0.00027229596,0.001258502,0.0001114228,0.00046997578,0.000067129324,0.00023901243,0.000102245256,0.002919762,0.99433136,0.000037321075],"about_ca_topic_score_codex":0.0020182128,"about_ca_topic_score_gemma":0.0060762404,"teacher_disagreement_score":0.02189023,"about_ca_system_score_codex":0.0036535542,"about_ca_system_score_gemma":0.0038851665,"threshold_uncertainty_score":0.056605995},"labels":[],"label_agreement":null},{"id":"W3004605337","doi":"10.2217/nmt-2019-0021","title":"Generalized Chorea Associated With Subcortical Leukoaraiosis of Binswanger Type: A Case Report","year":2020,"lang":"en","type":"article","venue":"Neurodegenerative Disease Management","topic":"Cerebrovascular and genetic disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital","funders":"","keywords":"Leukoaraiosis; Parkinsonism; Chorea; Hyperintensity; Choreiform movement; Psychology; White matter; Movement disorders; Dementia; Medicine; Magnetic resonance imaging; Cardiology; Neuroscience; Disease; Physical medicine and rehabilitation; Pathology; Radiology; Parkinson's disease; Dyskinesia","score_opus":0.02534283383478469,"score_gpt":0.2595627934979508,"score_spread":0.2342199596631661,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3004605337","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98297274,0.005339227,0.0025097218,0.0010457388,0.00021886457,0.00022887187,0.00017269385,0.00012652096,0.007385415],"genre_scores_gemma":[0.9939705,0.002545212,0.0011570293,0.00047752453,0.00067033997,0.000032234704,0.00007495973,0.000017767485,0.0010545978],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9995049,0.0000429123,0.00007352055,0.0001376041,0.000064788466,0.00017617818],"domain_scores_gemma":[0.99923444,0.00016491894,0.00020473627,0.00007164849,0.00005268498,0.0002715444],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026652514,0.0022684939,0.0011989898,0.0028895563,0.0029573038,0.00179233,0.0008171176,0.003131778,0.0020511856],"category_scores_gemma":[0.0013733977,0.0013222044,0.0008193631,0.0018668283,0.00168245,0.0017843491,0.0017276823,0.0019511285,0.00073286326],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015614272,0.00005148292,0.004870253,0.000024731806,0.000009055421,0.99324185,0.00022617537,0.000025586227,0.00042010238,0.00009129818,0.00016355903,0.000860231],"study_design_scores_gemma":[0.0000053412473,0.000028839531,0.002490119,0.000008145113,0.00001074129,0.9968631,0.000099925775,0.00005798497,0.00013099292,0.0000627214,0.00023436235,0.000007774523],"about_ca_topic_score_codex":0.0034579507,"about_ca_topic_score_gemma":0.004116844,"teacher_disagreement_score":0.0034579507,"about_ca_system_score_codex":0.0008812471,"about_ca_system_score_gemma":0.0007624537,"threshold_uncertainty_score":0.006875694},"labels":[],"label_agreement":null},{"id":"W3036437646","doi":"10.2217/nmt-2019-0030","title":"Evaluation of Antecedent Behaviors of dementia-related Wandering in Community and Facility Settings","year":2020,"lang":"en","type":"article","venue":"Neurodegenerative Disease Management","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"","keywords":"Antecedent (behavioral psychology); Dementia; Psychology; Medicine; Psychotherapist; Disease; Internal medicine","score_opus":0.045070280100665695,"score_gpt":0.3280030471940711,"score_spread":0.28293276709340537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3036437646","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99934393,0.00010836049,0.00009073617,0.000015618789,0.0000014585598,0.000055389315,0.00004203249,0.000003468815,0.00033905357],"genre_scores_gemma":[0.99902153,0.00017284915,0.00050954917,0.000011532242,0.0000018181084,0.000045162094,0.000109839435,7.892951e-7,0.00012698812],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99933535,0.00028367862,0.000105536536,0.00004587786,0.00012545305,0.000104103274],"domain_scores_gemma":[0.99659485,0.00070945837,0.0012797609,0.000116864154,0.00075780886,0.0005412059],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016006306,0.00025845206,0.00031029707,0.0013949402,0.0007776197,0.00051863753,0.00031288655,0.00024321151,0.0009373249],"category_scores_gemma":[0.008135356,0.0002022156,0.00035131266,0.00056623097,0.00027963665,0.00047598904,0.00088647194,0.00038195442,0.000097397155],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012637283,0.00034319214,0.9809403,0.00011020311,0.000025250883,0.00026941052,0.0049896818,0.000041893174,0.00033716846,0.000017479702,0.000080427715,0.012718616],"study_design_scores_gemma":[0.000005133444,0.0006144574,0.9884879,0.00005836924,0.00002338657,0.0003650307,0.009846711,0.000118398806,0.00027141746,0.000023191522,0.00017670366,0.00000933054],"about_ca_topic_score_codex":0.007077236,"about_ca_topic_score_gemma":0.015408493,"teacher_disagreement_score":0.007077236,"about_ca_system_score_codex":0.00075813814,"about_ca_system_score_gemma":0.0011861845,"threshold_uncertainty_score":0.01407212},"labels":[],"label_agreement":null},{"id":"W3163517945","doi":"10.2217/nmt-2021-0005","title":"Ozanimod for the Treatment of Relapsing Forms of Multiple Sclerosis","year":2021,"lang":"en","type":"article","venue":"Neurodegenerative Disease Management","topic":"Sphingolipid Metabolism and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Multiple Sclerosis Society of Canada; National Multiple Sclerosis Society","keywords":"Fingolimod; Medicine; Multiple sclerosis; Sphingosine-1-phosphate receptor; Tolerability; Receptor; Clinical trial; Bioinformatics; Internal medicine; Adverse effect; Sphingosine-1-phosphate; Immunology; Sphingosine; Biology","score_opus":0.03393061890345375,"score_gpt":0.2532120185054075,"score_spread":0.21928139960195372,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3163517945","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.017898805,0.97018784,0.0017614593,0.0013654667,0.00044063202,0.000059630787,0.00019591134,0.000109233326,0.0079809455],"genre_scores_gemma":[0.080548085,0.90611714,0.0028626164,0.0014147274,0.0004255194,0.00006134767,0.00051285914,0.000014962476,0.008042625],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999422,0.000009806944,0.000007996641,0.0000085369475,0.000022928016,0.000008554568],"domain_scores_gemma":[0.99997056,0.000006142695,0.000009369297,7.995018e-7,0.0000073034853,0.0000057885845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014610618,0.0002787646,0.00036173017,0.00057162263,0.00013100618,0.00026665351,0.00023287439,0.00039452428,0.002111837],"category_scores_gemma":[0.00011014533,0.000049138416,0.00023047376,0.0003136338,0.00012405278,0.00027269043,0.00026621405,0.0007236866,0.0007662022],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008576726,0.00015639733,0.00039525772,0.0052056955,0.00011396359,0.0009363154,0.00007722024,0.000218173,0.03939237,0.0022350473,0.014262877,0.93614906],"study_design_scores_gemma":[0.0003438646,0.0017938213,0.004484838,0.0009846067,0.0003357747,0.006561623,0.000085295935,0.0003189598,0.021372544,0.0014579269,0.9622256,0.00003515828],"about_ca_topic_score_codex":0.00035230507,"about_ca_topic_score_gemma":0.0011291864,"teacher_disagreement_score":0.002111837,"about_ca_system_score_codex":0.00018577157,"about_ca_system_score_gemma":0.00019329056,"threshold_uncertainty_score":0.0070647597},"labels":[],"label_agreement":null},{"id":"W3217773060","doi":"10.2217/nmt-2021-0042","title":"MN-166 (ibudilast) in Amyotrophic Lateral Sclerosis in a Phase IIb/III Study: COMBAT-ALS Study Design","year":2021,"lang":"en","type":"article","venue":"Neurodegenerative Disease Management","topic":"Amyotrophic Lateral Sclerosis Research","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Health Sciences Centre; Sunnybrook Health Science Centre; Montreal Neurological Institute and Hospital","funders":"","keywords":"Amyotrophic lateral sclerosis; Tolerability; Medicine; Neuroprotection; Riluzole; Quality of life (healthcare); Placebo; Clinical trial; Context (archaeology); Disease; Pharmacology; Internal medicine; Oncology; Adverse effect; Pathology","score_opus":0.08541449983593444,"score_gpt":0.3447099443251491,"score_spread":0.2592954444892147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3217773060","genre_codex":"empirical","genre_gemma":"protocol","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"protocol","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8970899,0.007692518,0.0037893846,0.002092707,0.0010004039,0.07715434,0.0032468354,0.00033100919,0.0076028686],"genre_scores_gemma":[0.8325346,0.0065260846,0.010067732,0.0057240925,0.0013715064,0.12628707,0.0035856634,0.0001166437,0.013786639],"study_design_codex":"randomized_trial","study_design_gemma":"not_applicable","domain_scores_codex":[0.99898964,0.00054453756,0.00006296409,0.00013946391,0.000077652454,0.0001857088],"domain_scores_gemma":[0.9992878,0.00008950656,0.00013637063,0.000057058583,0.00008250026,0.00034667653],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004093941,0.0029420783,0.0035785458,0.0005350411,0.000628763,0.0014600785,0.001044372,0.0022621718,0.005043418],"category_scores_gemma":[0.0014460083,0.0007984179,0.0013221124,0.00054671685,0.0013147471,0.0009111736,0.00051228155,0.002663313,0.0013891575],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9370204,0.026528254,0.0014729502,0.0010417538,0.00079995056,0.0001232054,0.00010612202,0.0005360497,0.014497161,0.0003604884,0.001926453,0.0155872535],"study_design_scores_gemma":[0.8363891,0.15745541,0.0019804472,0.00004197678,0.00046137502,0.000047177447,0.00003192003,0.0003662839,0.0008279694,0.00024521118,0.0021330533,0.000020063497],"about_ca_topic_score_codex":0.00065239577,"about_ca_topic_score_gemma":0.0015911525,"teacher_disagreement_score":0.005043418,"about_ca_system_score_codex":0.00078642735,"about_ca_system_score_gemma":0.0028884038,"threshold_uncertainty_score":0.02165109},"labels":[],"label_agreement":null},{"id":"W4206167951","doi":"10.2217/nmt-2021-0041","title":"Side Effects That Occurred Early in People With Multiple Sclerosis During the First Year of Treatment With Cladribine Tablets: A Plain Language Summary","year":2022,"lang":"en","type":"letter","venue":"Neurodegenerative Disease Management","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Cladribine; Medicine; Placebo; Multiple sclerosis; Side effect (computer science); Dosing; Internal medicine; Alternative medicine; Psychiatry; Pathology","score_opus":0.016150902755551755,"score_gpt":0.2300972813157672,"score_spread":0.21394637856021545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206167951","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.030549059,0.009942748,0.000545876,0.91303205,0.014367111,0.00012861822,0.0006640507,0.00018706667,0.030583361],"genre_scores_gemma":[0.14866605,0.010000477,0.0009986853,0.7641564,0.05151421,0.00016005927,0.00038554883,0.00007717597,0.024041409],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99843735,0.00052796677,0.0003334274,0.00013295817,0.00044248102,0.00012581961],"domain_scores_gemma":[0.9915766,0.0041655237,0.0013762863,0.00022359843,0.0021096123,0.0005484705],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001521347,0.0002471994,0.00046417344,0.00043954974,0.0010513765,0.0010150138,0.00036099384,0.0050796103,0.0038806312],"category_scores_gemma":[0.014507656,0.00018684988,0.00044693207,0.00044373676,0.00048201278,0.00076341856,0.00027844665,0.0032214783,0.0021994999],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044296368,0.00011459663,0.016558412,0.00047038484,0.000044553024,0.012854224,0.00055594806,0.000065745015,0.0011619603,0.0009005195,0.8862778,0.08055291],"study_design_scores_gemma":[0.00082934723,0.0011917019,0.08191583,0.0031185448,0.00022336109,0.08746218,0.0020008294,0.0014268735,0.0015802275,0.0033581594,0.8167504,0.00014252924],"about_ca_topic_score_codex":0.0025702615,"about_ca_topic_score_gemma":0.0050098496,"teacher_disagreement_score":0.0050796103,"about_ca_system_score_codex":0.0016611558,"about_ca_system_score_gemma":0.0010283289,"threshold_uncertainty_score":0.012981951},"labels":[],"label_agreement":null},{"id":"W4225964837","doi":"10.2217/nmt-2021-0053","title":"Recruitment of Participants for Dementia Research: Interprofessional Perspectives From Primary care-based Memory Clinics","year":2022,"lang":"en","type":"article","venue":"Neurodegenerative Disease Management","topic":"Ethics in Clinical Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Family Medicine; Research Institute for Aging; McMaster University; University of Waterloo","funders":"","keywords":"Dementia; Primary care; Memory clinic; Psychology; Medicine; Nursing; Gerontology; Family medicine; Disease","score_opus":0.6474344058802497,"score_gpt":0.5855558567545249,"score_spread":0.06187854912572477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225964837","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90772766,0.006079737,0.0036494285,0.071015365,0.0006600474,0.0007041163,0.00009532264,0.000046563662,0.010021832],"genre_scores_gemma":[0.9657069,0.0030356261,0.0025815177,0.02637436,0.00034564032,0.00043398965,0.000045640947,0.000022825361,0.001453469],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.93980014,0.04995251,0.0022759868,0.0012070171,0.0033192085,0.0034452302],"domain_scores_gemma":[0.8787048,0.0694799,0.013805539,0.002076453,0.012346083,0.023587195],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.05351584,0.0004368411,0.0008931894,0.0011644763,0.01106538,0.008529124,0.0015804817,0.0035683857,0.0041550025],"category_scores_gemma":[0.07882836,0.00070762984,0.00058084965,0.0007786323,0.0045048012,0.0044112545,0.007998971,0.005082713,0.0006321212],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022922513,0.00032027977,0.02819118,0.0010363287,0.0000602217,0.0032742159,0.9287246,0.000042120864,0.0018796666,0.00075944525,0.00519789,0.030284954],"study_design_scores_gemma":[0.00008195764,0.00058630976,0.01331744,0.001299827,0.000046019253,0.0019606403,0.9654965,0.00007926927,0.00036205855,0.0008391698,0.015876347,0.00005440906],"about_ca_topic_score_codex":0.0033869946,"about_ca_topic_score_gemma":0.0077717686,"teacher_disagreement_score":0.94648415,"about_ca_system_score_codex":0.0029522015,"about_ca_system_score_gemma":0.010983995,"threshold_uncertainty_score":0.28302217},"labels":[],"label_agreement":null},{"id":"W4241021086","doi":"10.2217/nmt.12.67","title":"Journal Watch: Our Panel of Experts Highlight the Most Important Research Articles Across the Spectrum of Topics Relevant to the Field of Neurodegenerative Disease Management","year":2012,"lang":"en","type":"article","venue":"Neurodegenerative Disease Management","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"","keywords":"Field (mathematics); Disease; Broad spectrum; Data science; Medicine; Computer science; Pathology","score_opus":0.057572695240666404,"score_gpt":0.3531565859360407,"score_spread":0.29558389069537433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4241021086","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001359165,0.035409685,0.0015390008,0.49155217,0.4602155,0.00041781706,0.0007064319,0.0003231047,0.008477167],"genre_scores_gemma":[0.0043601813,0.027755609,0.005400023,0.2244413,0.70679456,0.00036631434,0.0007433094,0.000259009,0.029879693],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99473995,0.00075624627,0.0013530453,0.0004620469,0.0021106745,0.0005780709],"domain_scores_gemma":[0.8859471,0.028804792,0.012044122,0.0014334059,0.050871365,0.0208991],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010938804,0.0021047175,0.0035636062,0.008678126,0.003490189,0.0077796346,0.0024442982,0.01552554,0.028234892],"category_scores_gemma":[0.044044625,0.00074819085,0.0020039827,0.0053210743,0.0016475462,0.0055751647,0.0036963476,0.009132565,0.013771389],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006937323,0.00003845415,0.00073198316,0.00077911146,0.000033262477,0.00037156977,0.00009740351,0.000030621297,0.00071772747,0.00012260838,0.9746105,0.02239743],"study_design_scores_gemma":[0.0000848515,0.00006914356,0.003913439,0.0019594124,0.00011810498,0.0011208782,0.0006709864,0.00018778688,0.0005078458,0.0010456737,0.99025565,0.00006637541],"about_ca_topic_score_codex":0.0013043898,"about_ca_topic_score_gemma":0.0055733435,"teacher_disagreement_score":0.028234892,"about_ca_system_score_codex":0.001826335,"about_ca_system_score_gemma":0.003271135,"threshold_uncertainty_score":0.09445512},"labels":[],"label_agreement":null},{"id":"W4280536183","doi":"10.2217/nmt-2021-0055","title":"Glutamate Modulation for the Treatment of Levodopa Induced Dyskinesia: A Brief Review of the Drugs Tested in the Clinic","year":2022,"lang":"en","type":"review","venue":"Neurodegenerative Disease Management","topic":"Neuroscience and Neuropharmacology Research","field":"Neuroscience","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre; Université de Montréal; Montreal Neurological Institute and Hospital","funders":"","keywords":"Dyskinesia; Levodopa; Glutamate receptor; Pharmacology; Medicine; Internal medicine; Disease; Parkinson's disease","score_opus":0.20330965741343715,"score_gpt":0.43184195866469227,"score_spread":0.22853230125125512,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280536183","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013476949,0.9986474,0.00010878884,0.00013712332,0.00014612928,0.000006893452,0.00002941788,0.0000086082155,0.00078087125],"genre_scores_gemma":[0.0006818589,0.99829274,0.0001896422,0.00018687041,0.00012344233,0.000009912037,0.000040910807,0.0000015600805,0.00047312313],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998889,0.000020728361,0.000020473333,0.000020577312,0.000035566278,0.000013755505],"domain_scores_gemma":[0.99983513,0.00008498843,0.00002544159,0.0000049191212,0.000033244578,0.000016283517],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041567086,0.00094843016,0.0012685553,0.0016809643,0.00020132218,0.0006883508,0.0008842533,0.000883069,0.0035762067],"category_scores_gemma":[0.00046174624,0.0002644851,0.00056681794,0.0014940526,0.0002785311,0.00081163854,0.00044791706,0.001784777,0.0025062237],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020757777,0.00014372557,0.00009126635,0.0172574,0.000128682,0.00032028352,0.000041334813,0.0002927849,0.0039173295,0.002262734,0.029611815,0.9457251],"study_design_scores_gemma":[0.0000883294,0.000466371,0.0009211581,0.004509519,0.0002740476,0.0022853946,0.000042536114,0.00016011618,0.0012370972,0.0016579747,0.98832124,0.000036180303],"about_ca_topic_score_codex":0.000880751,"about_ca_topic_score_gemma":0.0027499108,"teacher_disagreement_score":0.0035762067,"about_ca_system_score_codex":0.00037762063,"about_ca_system_score_gemma":0.0006034203,"threshold_uncertainty_score":0.0119636655},"labels":[],"label_agreement":null},{"id":"W4286698798","doi":"10.2217/nmt-2022-0013","title":"The AT(N) System for Describing Biological Changes in Alzheimer’s Disease: A Plain Language Summary","year":2022,"lang":"en","type":"article","venue":"Neurodegenerative Disease Management","topic":"Biological Research and Disease Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nutrasource","funders":"","keywords":"Disease; Dementia; Neurodegeneration; Neuroscience; Neurology; Alzheimer's disease; Medicine; Psychology; Pathology","score_opus":0.052728695708741675,"score_gpt":0.2915170587720517,"score_spread":0.23878836306331003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4286698798","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015411655,0.049779676,0.080268905,0.077607915,0.10708376,0.0035046753,0.14496365,0.030742126,0.50450826],"genre_scores_gemma":[0.0132210255,0.06926743,0.14076118,0.11700318,0.036845047,0.0077196844,0.14402969,0.026178855,0.44497395],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9955,0.0014438091,0.0014203328,0.00028887144,0.0010319304,0.0003150192],"domain_scores_gemma":[0.9746104,0.0085812295,0.0022158916,0.001404905,0.011726119,0.0014615619],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005340497,0.0024143977,0.0017874815,0.006312731,0.0014661736,0.008214765,0.0028839963,0.0040066647,0.20509654],"category_scores_gemma":[0.030243266,0.0010097235,0.0016508225,0.007450774,0.0012842758,0.007840666,0.0035869514,0.0046280813,0.32622623],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005034872,0.000015303518,0.00013764804,0.0007179668,0.0000055900086,0.000074764816,0.00010511512,0.00006642615,0.00029317455,0.0024792613,0.9678454,0.028209087],"study_design_scores_gemma":[0.000011809415,0.000022356942,0.0002947827,0.0007414986,0.0000055630453,0.00023770863,0.00007766619,0.00009073311,0.00011181905,0.0012629199,0.9971264,0.000016797181],"about_ca_topic_score_codex":0.006749697,"about_ca_topic_score_gemma":0.0055372175,"teacher_disagreement_score":0.20509654,"about_ca_system_score_codex":0.0026049316,"about_ca_system_score_gemma":0.004538124,"threshold_uncertainty_score":0.6861163},"labels":[],"label_agreement":null},{"id":"W4368360153","doi":"10.2217/nmt-2022-0039","title":"5-HT <sub>1A</sub> Agonists for levodopa-induced Dyskinesia in Parkinson’s Disease","year":2023,"lang":"en","type":"review","venue":"Neurodegenerative Disease Management","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre; Montreal Neurological Institute and Hospital","funders":"","keywords":"Dyskinesia; Levodopa; Medicine; Parkinson's disease; Disease; Adverse effect; Clinical trial; Pharmacology; Internal medicine","score_opus":0.08036623754658324,"score_gpt":0.34309356382898115,"score_spread":0.2627273262823979,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4368360153","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010409823,0.9987973,0.00005061353,0.00010960845,0.00009586047,0.00000788922,0.000027459719,0.000007687909,0.0007994603],"genre_scores_gemma":[0.00048334667,0.9986583,0.000113192575,0.00013657643,0.000063320396,0.0000075573093,0.000033857108,0.0000011476071,0.00050275587],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99989605,0.000016788956,0.000018492967,0.000016269327,0.00004175264,0.000010690137],"domain_scores_gemma":[0.99986553,0.00005709222,0.000028701557,0.000003432345,0.000032432716,0.000012791832],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034343012,0.00073589425,0.0012518985,0.0022249066,0.00021015081,0.0007492026,0.0005408471,0.0007353352,0.0061369287],"category_scores_gemma":[0.0003421388,0.00019039263,0.00058517867,0.0019063642,0.00020292659,0.0006800645,0.00045126502,0.0011645455,0.0032713993],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008661025,0.00006556648,0.00008997594,0.03535834,0.0001294258,0.0001595057,0.000043817363,0.00019599638,0.0017965239,0.0015553752,0.022299904,0.93821895],"study_design_scores_gemma":[0.000052135158,0.00017690631,0.0013781124,0.011822848,0.00040455753,0.0015196828,0.00007366525,0.00009474966,0.0005117365,0.0012881504,0.9826584,0.000019041741],"about_ca_topic_score_codex":0.0010131901,"about_ca_topic_score_gemma":0.0028816604,"teacher_disagreement_score":0.0061369287,"about_ca_system_score_codex":0.0003711688,"about_ca_system_score_gemma":0.0006174581,"threshold_uncertainty_score":0.020530045},"labels":[],"label_agreement":null},{"id":"W4379768482","doi":"10.2217/nmt-2023-0005","title":"A Plain Language Summary On the Effectiveness of Cladribine Tablets Compared With Other Oral Treatments for Multiple Sclerosis: Results From the Msbase Registry","year":2023,"lang":"en","type":"article","venue":"Neurodegenerative Disease Management","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Cladribine; Multiple sclerosis; Medicine; Dermatology; Medical physics; Natural language processing; Internal medicine; Computer science; Immunology","score_opus":0.05009979747776734,"score_gpt":0.28861253366580564,"score_spread":0.2385127361880383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379768482","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.059791204,0.16306067,0.0029502832,0.013704132,0.0049373726,0.0030020566,0.7243153,0.0016028348,0.026636131],"genre_scores_gemma":[0.24891104,0.15221527,0.009554364,0.021941537,0.009769728,0.005918369,0.5266458,0.00075927435,0.024284583],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99090004,0.0032235454,0.0029195873,0.00036405763,0.002392717,0.00020009684],"domain_scores_gemma":[0.95354724,0.021810396,0.013686679,0.0011338613,0.0089483885,0.00087349775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006908152,0.0012567467,0.0042916806,0.004628646,0.00034457253,0.001981666,0.0012583607,0.0010805828,0.017341869],"category_scores_gemma":[0.02491095,0.00042054415,0.0041489676,0.004480717,0.00028572843,0.0017176748,0.0006182922,0.0012325423,0.005085016],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.041281655,0.000952501,0.03214267,0.0637663,0.009858274,0.00040949727,0.00036188634,0.0016364042,0.0026079845,0.0007270803,0.59092224,0.2553335],"study_design_scores_gemma":[0.020384323,0.028959246,0.39984557,0.021211935,0.027741313,0.0019117355,0.00090740295,0.0012443187,0.005018518,0.0010569227,0.49118346,0.00053527736],"about_ca_topic_score_codex":0.0020683962,"about_ca_topic_score_gemma":0.0025697788,"teacher_disagreement_score":0.017341869,"about_ca_system_score_codex":0.000985043,"about_ca_system_score_gemma":0.0015260858,"threshold_uncertainty_score":0.058014393},"labels":[],"label_agreement":null},{"id":"W4380290882","doi":"10.2217/nmt-2023-0016","title":"Targeting Metabotropic Glutamate Receptors for the Treatment of Parkinson’s Disease","year":2023,"lang":"en","type":"editorial","venue":"Neurodegenerative Disease Management","topic":"Neuroscience and Neuropharmacology Research","field":"Neuroscience","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre; Montreal Neurological Institute and Hospital","funders":"","keywords":"Metabotropic glutamate receptor; Neuroscience; Metabotropic receptor; Metabotropic glutamate receptor 2; Glutamate receptor; Ionotropic effect; Neurology; Metabotropic glutamate receptor 1; Medicine; Library science; Psychology; Receptor; Computer science; Internal medicine","score_opus":0.0482757096830858,"score_gpt":0.3458132350979046,"score_spread":0.2975375254148188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380290882","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000055458077,0.018030494,0.00022464401,0.020987235,0.9587427,0.000028845423,0.000042075324,0.000051157607,0.0018374618],"genre_scores_gemma":[0.00049042015,0.012329585,0.00012479741,0.01393119,0.96559304,0.000021659504,0.000022396547,0.000019295767,0.0074675423],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970951,0.0005878865,0.00040442485,0.00028308507,0.0014426018,0.00018695495],"domain_scores_gemma":[0.9914595,0.0037310293,0.00051935524,0.0001628011,0.0026814423,0.0014458813],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0059688613,0.0039269677,0.0035396784,0.0023268068,0.0018574797,0.0041878223,0.002965436,0.014140602,0.007780382],"category_scores_gemma":[0.011042731,0.00097129797,0.0026837934,0.00089397834,0.0017562313,0.0028096589,0.0010412461,0.017832495,0.0061221803],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012772376,0.000025436622,0.00001880752,0.00044303382,0.00004174346,0.00017934515,0.000010505123,0.000046612044,0.0001702929,0.00045251634,0.9865674,0.011916637],"study_design_scores_gemma":[0.00027613126,0.00014394509,0.00034912268,0.00068339234,0.00015902937,0.00071925984,0.000036648085,0.00039840295,0.00030669622,0.0017142331,0.99517775,0.00003534864],"about_ca_topic_score_codex":0.0018020476,"about_ca_topic_score_gemma":0.005936717,"teacher_disagreement_score":0.014140602,"about_ca_system_score_codex":0.0025618416,"about_ca_system_score_gemma":0.0021161232,"threshold_uncertainty_score":0.03156668},"labels":[],"label_agreement":null},{"id":"W4394716210","doi":"10.2217/nmt-2024-0005","title":"Glycine and clozapine: potential relevance for the treatment of Parkinson's disease","year":2024,"lang":"en","type":"editorial","venue":"Neurodegenerative Disease Management","topic":"Neurological disorders and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital; McGill University Health Centre; Talon Pharmaceuticals (Canada)","funders":"","keywords":"Clozapine; Psychiatry; Medicine; MEDLINE; Schizophrenia (object-oriented programming); Psychology; Political science","score_opus":0.012632320902543114,"score_gpt":0.2793851781595325,"score_spread":0.2667528572569894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394716210","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000048248963,0.049249273,0.00010425912,0.04391221,0.9045803,0.0000247058,0.00005726915,0.000050416846,0.0019733],"genre_scores_gemma":[0.00040784237,0.02760706,0.00012090113,0.03474556,0.9296648,0.000025168096,0.000032824635,0.00002451325,0.007371343],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969506,0.0008326477,0.00053790136,0.00028770402,0.0012257058,0.00016543274],"domain_scores_gemma":[0.9879937,0.0065043424,0.00065934076,0.00022476411,0.0032436345,0.0013742589],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0075380965,0.003845571,0.0035798603,0.0028274136,0.00213708,0.0051508755,0.0035273011,0.01612479,0.009383335],"category_scores_gemma":[0.015158309,0.0009621562,0.002987545,0.0015544958,0.0023330217,0.0046315906,0.001191192,0.021547826,0.008419233],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011292435,0.000017552886,0.000019459461,0.0005695697,0.0000375097,0.00012390409,0.000011496949,0.00003193557,0.00006515081,0.0004312598,0.98733926,0.011239982],"study_design_scores_gemma":[0.00026296513,0.00009933398,0.00036149434,0.0012339541,0.000161449,0.00044964268,0.00004826345,0.00019817683,0.00009760891,0.0019789012,0.9950761,0.000032089494],"about_ca_topic_score_codex":0.0028965,"about_ca_topic_score_gemma":0.008589351,"teacher_disagreement_score":0.01612479,"about_ca_system_score_codex":0.0035560557,"about_ca_system_score_gemma":0.0030523906,"threshold_uncertainty_score":0.039865732},"labels":[],"label_agreement":null},{"id":"W4401716166","doi":"10.1080/17582024.2024.2389034","title":"A discussion with Philippe Huot: the challenges of discovering novel therapies for the treatment of Parkinson’s disease","year":2024,"lang":"en","type":"article","venue":"Neurodegenerative Disease Management","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; McGill University Health Centre; Montreal Neurological Institute and Hospital","funders":"","keywords":"Disease; Parkinson's disease; Medicine; Psychology; Psychotherapist; Intensive care medicine; Internal medicine","score_opus":0.03575226532805799,"score_gpt":0.2819761750557222,"score_spread":0.24622390972766423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401716166","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004688607,0.0071354723,0.00011354803,0.9782649,0.014147691,0.0000043183977,0.0000129212185,0.000009833695,0.0002643646],"genre_scores_gemma":[0.0012099231,0.008057913,0.0005472499,0.9645058,0.023504846,0.000026301059,0.000011231099,0.000037890288,0.002098742],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98638386,0.006549586,0.0011139155,0.0017448396,0.003290678,0.0009171329],"domain_scores_gemma":[0.940732,0.04004539,0.0015019854,0.0010201936,0.008807334,0.007893088],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03062946,0.0017955601,0.0038897998,0.0014091771,0.008268833,0.009089061,0.0049679247,0.04355923,0.0079636],"category_scores_gemma":[0.059005182,0.0011442351,0.002236132,0.001395998,0.012570854,0.025029382,0.0055897394,0.097685345,0.0036574458],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000043130443,0.00002606615,0.00010145544,0.00016408083,0.000019035986,0.00032152564,0.0004930657,0.000054151016,0.00009037076,0.004966884,0.98358387,0.010136444],"study_design_scores_gemma":[0.000068108406,0.00007331312,0.00024250051,0.00082885986,0.000030403919,0.0014969667,0.0020152056,0.00024461185,0.00029393425,0.017211556,0.9773681,0.00012646742],"about_ca_topic_score_codex":0.0092622535,"about_ca_topic_score_gemma":0.015955744,"teacher_disagreement_score":0.04355923,"about_ca_system_score_codex":0.0052982243,"about_ca_system_score_gemma":0.012930384,"threshold_uncertainty_score":0.161986},"labels":[],"label_agreement":null},{"id":"W4403141700","doi":"10.1080/17582024.2024.2404378","title":"Mapping the journey of patients and care partners living with adult-onset leukoencephalopathy with axonal spheroids and pigmented glia: developing a framework for improvements in care","year":2024,"lang":"en","type":"article","venue":"Neurodegenerative Disease Management","topic":"Neuroinflammation and Neurodegeneration Mechanisms","field":"Neuroscience","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Leukoencephalopathy; Spheroid; Medicine; Neuroscience; Psychology; Biology; Pathology; Genetics","score_opus":0.02656992698641835,"score_gpt":0.26886204923607115,"score_spread":0.2422921222496528,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403141700","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7494356,0.010588396,0.02489719,0.18075463,0.0006706607,0.002338801,0.0025715453,0.0004900799,0.028253097],"genre_scores_gemma":[0.9203737,0.01005764,0.05820602,0.0060005877,0.00007906425,0.0016060764,0.0013257177,0.0000760162,0.002275177],"study_design_codex":"design_other","study_design_gemma":"qualitative","domain_scores_codex":[0.9936226,0.004367442,0.00045265103,0.00030812752,0.0004539975,0.00079518714],"domain_scores_gemma":[0.991012,0.0029837892,0.0013735611,0.00028614383,0.001745036,0.0025995257],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008929452,0.00050041004,0.00058536866,0.0019527226,0.004810321,0.006094878,0.001819065,0.0014646448,0.0028953927],"category_scores_gemma":[0.019807264,0.00041391072,0.00082505035,0.0016386844,0.0014835952,0.006057157,0.009954622,0.0032398568,0.00058296754],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033327576,0.001236397,0.27846166,0.0052174875,0.00023874611,0.003903974,0.29457107,0.0024453674,0.0012637174,0.012284845,0.056351498,0.343692],"study_design_scores_gemma":[0.000045689612,0.00070657936,0.082538396,0.0059499154,0.00011646419,0.0014841149,0.8048459,0.0031670132,0.0008033531,0.014799223,0.08535398,0.00018938126],"about_ca_topic_score_codex":0.021901283,"about_ca_topic_score_gemma":0.043964535,"teacher_disagreement_score":0.021901283,"about_ca_system_score_codex":0.005564194,"about_ca_system_score_gemma":0.023239685,"threshold_uncertainty_score":0.047223985},"labels":[],"label_agreement":null},{"id":"W4412047533","doi":"10.1080/17582024.2025.2528557","title":"Recent and on-going trials for the treatment of levodopa-induced dyskinesia: a review of the clinical trial databases","year":2025,"lang":"en","type":"review","venue":"Neurodegenerative Disease Management","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Montreal Neurological Institute and Hospital; McGill University","funders":"","keywords":"Dyskinesia; Clinical trial; Levodopa; Medicine; Database; Computer science; Parkinson's disease; Disease; Internal medicine","score_opus":0.37262730765084734,"score_gpt":0.48677388211945816,"score_spread":0.11414657446861082,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412047533","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013509304,0.99898297,0.00008626681,0.00016234696,0.00006537009,0.000032471773,0.00010473993,0.0000067721635,0.0004239076],"genre_scores_gemma":[0.00074329576,0.9984975,0.00024106473,0.0002159887,0.000042157804,0.000032485408,0.00010279319,0.000002091223,0.000122592],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9993349,0.00016369726,0.00021965672,0.000088745786,0.00016349115,0.000029496698],"domain_scores_gemma":[0.99709105,0.0019322596,0.0004902501,0.000048506354,0.00035648164,0.0000813289],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002171526,0.0009413666,0.0034421335,0.0031716453,0.00025348752,0.0011540486,0.0016978428,0.0010683612,0.0069306977],"category_scores_gemma":[0.0037120392,0.00037370104,0.0018391851,0.004194732,0.00036866838,0.0010398716,0.0006052032,0.0010867899,0.0010377256],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004759218,0.00007671855,0.00022330238,0.26084122,0.0010432439,0.00016052039,0.00007502818,0.00028308848,0.000829415,0.0013228796,0.015376136,0.7192925],"study_design_scores_gemma":[0.0005767445,0.00077593175,0.0033564859,0.21285248,0.010829865,0.0015877464,0.00024338641,0.00027532672,0.0008726249,0.0023787685,0.76617163,0.00007897705],"about_ca_topic_score_codex":0.0011046208,"about_ca_topic_score_gemma":0.0030875085,"teacher_disagreement_score":0.0069306977,"about_ca_system_score_codex":0.0008009093,"about_ca_system_score_gemma":0.002098145,"threshold_uncertainty_score":0.023185551},"labels":[],"label_agreement":null},{"id":"W4412509421","doi":"10.1080/17582024.2025.2520709","title":"A drug evaluation narrative review of cladribine as a treatment for multiple sclerosis","year":2025,"lang":"en","type":"review","venue":"Neurodegenerative Disease Management","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Cladribine; Multiple sclerosis; Drug; Narrative; Medicine; Intensive care medicine; Pharmacology; Internal medicine; Psychiatry; Philosophy; Linguistics","score_opus":0.18322779336882317,"score_gpt":0.432603153387454,"score_spread":0.2493753600186308,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412509421","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000114609924,0.99854714,0.000055055665,0.000115546056,0.00011355578,0.000022017217,0.00006961401,0.0000046216965,0.00095771777],"genre_scores_gemma":[0.0009010581,0.99800426,0.00017418801,0.00020715917,0.00007313059,0.00002735444,0.00008277738,0.0000014090832,0.0005286603],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996909,0.00006868422,0.000079576894,0.000039775263,0.00010417826,0.000016898699],"domain_scores_gemma":[0.99941206,0.00034409657,0.0001087778,0.00001033213,0.000100972204,0.000023740784],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000595627,0.00066536485,0.0014962893,0.0025732915,0.0002635143,0.00088851963,0.0007170564,0.0007626641,0.008735292],"category_scores_gemma":[0.0014169208,0.00023363407,0.0010393828,0.002307157,0.00021476772,0.0007264426,0.00043723916,0.00085162325,0.0014597956],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001770608,0.000058034384,0.00010976198,0.14297812,0.000356907,0.00022180757,0.00007483953,0.00028398965,0.001029,0.0022680021,0.035032675,0.81740993],"study_design_scores_gemma":[0.00007782747,0.00024048687,0.0009759696,0.04745292,0.0011554069,0.0013024398,0.000059129758,0.000116525756,0.00038459332,0.00081741204,0.9473958,0.00002136876],"about_ca_topic_score_codex":0.0015353784,"about_ca_topic_score_gemma":0.0035661282,"teacher_disagreement_score":0.008735292,"about_ca_system_score_codex":0.00052344205,"about_ca_system_score_gemma":0.0013623786,"threshold_uncertainty_score":0.029222488},"labels":[],"label_agreement":null},{"id":"W4413832847","doi":"10.1080/17582024.2025.2552610","title":"Real-world safety and tolerability of intravenous edaravone in patients with amyotrophic lateral sclerosis","year":2025,"lang":"en","type":"article","venue":"Neurodegenerative Disease Management","topic":"Amyotrophic Lateral Sclerosis Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Tolerability; Amyotrophic lateral sclerosis; Edaravone; Medicine; Multiple sclerosis; Anesthesia; Adverse effect; Disease; Internal medicine; Psychiatry","score_opus":0.012566844088563105,"score_gpt":0.2552399923075464,"score_spread":0.2426731482189833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413832847","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99871624,0.00032281436,0.00010049722,0.000023580007,0.0000037555556,0.000019728852,0.00042641987,0.0000030028716,0.00038400816],"genre_scores_gemma":[0.9991554,0.000098771154,0.00007888531,0.000035496323,0.0000123208165,0.000020387226,0.00052716845,0.0000019919203,0.00006967728],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989249,0.00029680177,0.0002003089,0.00027193548,0.00020001475,0.00010596548],"domain_scores_gemma":[0.9962077,0.00056799315,0.0025797994,0.00021712967,0.00024978747,0.00017767095],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001237494,0.00020716838,0.00034273576,0.00043130762,0.0003101758,0.0009149292,0.00020288324,0.00030016873,0.00084886944],"category_scores_gemma":[0.0032119513,0.00014954737,0.0005868627,0.0005095286,0.00030819053,0.0005263391,0.00031347745,0.00038987174,0.00018205267],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000842016,0.00009234407,0.9950413,0.000033917127,0.00013717273,0.00019133807,0.0000890522,0.000086476146,0.00031426293,0.00001407521,0.00009324237,0.0030648545],"study_design_scores_gemma":[0.00007828716,0.0016151865,0.99542135,0.000024735282,0.00010316781,0.0012340825,0.00025477825,0.00025082252,0.0003096772,0.000032373846,0.00066251727,0.000013002806],"about_ca_topic_score_codex":0.0011319903,"about_ca_topic_score_gemma":0.0013355744,"teacher_disagreement_score":0.001237494,"about_ca_system_score_codex":0.00042685412,"about_ca_system_score_gemma":0.0003503377,"threshold_uncertainty_score":0.00654459},"labels":[],"label_agreement":null},{"id":"W4416150722","doi":"10.1080/17582024.2025.2587549","title":"Identifying a combination of biomarkers to predict treatment response to nabilone for agitation in Alzheimer’s disease – an exploratory <i>post hoc</i> analysis","year":2025,"lang":"en","type":"article","venue":"Neurodegenerative Disease Management","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Baycrest Hospital; Health Sciences Centre; Sunnybrook Hospital; University of Toronto; Centre for Addiction and Mental Health; Sunnybrook Health Science Centre","funders":"Alzheimer Society; Weston Brain Institute","keywords":"Disease; Exploratory analysis; Biomarker; MEDLINE; Clinical trial","score_opus":0.03510451417143287,"score_gpt":0.36031666314805205,"score_spread":0.3252121489766192,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416150722","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936267,0.00083430985,0.0029383777,0.00016948707,0.00006335094,0.0009905086,0.00058108673,0.000048497768,0.0007475964],"genre_scores_gemma":[0.9925746,0.00016623856,0.00440635,0.00012706556,0.00006336176,0.001168442,0.00090248056,0.000026500562,0.00056495296],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99459404,0.0035544666,0.0002559809,0.00062538334,0.0005089242,0.00046122898],"domain_scores_gemma":[0.9930227,0.0038846345,0.0010611723,0.0006309149,0.00076683733,0.00063376856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009496611,0.0016767372,0.0023861353,0.000738583,0.0004729928,0.0013357195,0.001029826,0.00074466417,0.0024473043],"category_scores_gemma":[0.008637332,0.00060996064,0.0057723434,0.0006218265,0.00062335626,0.0008838199,0.0007260923,0.0014965031,0.00048341713],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3799046,0.006750732,0.51865137,0.0008778715,0.022153484,0.00026757704,0.00050198525,0.003770229,0.015363617,0.00021574095,0.0015457628,0.049997028],"study_design_scores_gemma":[0.015622059,0.18807808,0.73499954,0.00012626768,0.024694562,0.0003989076,0.00046607436,0.020592142,0.011201456,0.0006904032,0.0029557396,0.00017477848],"about_ca_topic_score_codex":0.0011879943,"about_ca_topic_score_gemma":0.0015347908,"teacher_disagreement_score":0.009496611,"about_ca_system_score_codex":0.0008825042,"about_ca_system_score_gemma":0.0019054028,"threshold_uncertainty_score":0.05022347},"labels":[],"label_agreement":null},{"id":"W4416224024","doi":"10.1080/17582024.2025.2580854","title":"Dancing through the darkness: a systematic review of dance as a multidimensional therapy for Parkinson’s disease","year":2025,"lang":"en","type":"article","venue":"Neurodegenerative Disease Management","topic":"Balance, Gait, and Falls Prevention","field":"Health Professions","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University","funders":"","keywords":"Dance; Dance therapy; Modalities; Disease; Treatment modality; Sample (material)","score_opus":0.027143982558418444,"score_gpt":0.36884427541214787,"score_spread":0.34170029285372944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416224024","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00057750236,0.99859303,0.00009533202,0.00017934876,0.000073143456,0.0001850765,0.00013905084,0.000004936023,0.00015253318],"genre_scores_gemma":[0.009042132,0.98931855,0.00053459965,0.00039496535,0.000053450913,0.00044077876,0.00012505369,0.0000038588114,0.00008658251],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99468476,0.0019523673,0.0018898266,0.00042251442,0.0008974814,0.00015302961],"domain_scores_gemma":[0.9850647,0.010527143,0.0026304098,0.0002438725,0.0012788686,0.000254981],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0070879976,0.0013896313,0.00784127,0.008863095,0.00079875387,0.002641139,0.0017022921,0.0016265118,0.0035272427],"category_scores_gemma":[0.023171213,0.00074218103,0.0070582926,0.009058559,0.00092135806,0.0017154556,0.0015197158,0.0010762643,0.0002374088],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013075722,0.00001609433,0.00034152975,0.95858204,0.006104133,0.00005509541,0.00018020008,0.00006189683,0.00012545846,0.00015250388,0.00093933364,0.033310812],"study_design_scores_gemma":[0.00017752087,0.00019422306,0.0029495757,0.92800987,0.051623438,0.0002536434,0.00025015767,0.00007001358,0.00011669903,0.0002739786,0.016050084,0.000030699794],"about_ca_topic_score_codex":0.009146257,"about_ca_topic_score_gemma":0.03321441,"teacher_disagreement_score":0.009146257,"about_ca_system_score_codex":0.0031241472,"about_ca_system_score_gemma":0.013081302,"threshold_uncertainty_score":0.0374853},"labels":[],"label_agreement":null},{"id":"W4416941498","doi":"10.1080/17582024.2025.2577054","title":"Practices and perceptions around splitting of carbidopa/levodopa tablets: a survey of patients and neurologists","year":2025,"lang":"en","type":"article","venue":"Neurodegenerative Disease Management","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Movement Disorders","funders":"","keywords":"Perception; Pill; Clinical Practice; MEDLINE; Best practice","score_opus":0.05320989404168995,"score_gpt":0.37125200439510636,"score_spread":0.3180421103534164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416941498","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99892944,0.0002134694,0.000018139708,0.00026271763,0.0000036141314,0.000008967601,0.0000703603,0.0000011468507,0.00049216475],"genre_scores_gemma":[0.9992908,0.00026015192,0.000052467076,0.00021111248,0.000005589607,0.000010686907,0.000055906705,8.6051534e-7,0.00011235948],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987921,0.00048821562,0.00017471747,0.00010672394,0.00025164595,0.00018654659],"domain_scores_gemma":[0.9942015,0.0017035564,0.002511256,0.00010769447,0.00056923804,0.00090669206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018953616,0.00013442399,0.00032005284,0.00073201273,0.0008382414,0.0010462352,0.00027106388,0.0007427308,0.0014590771],"category_scores_gemma":[0.0064851353,0.0002646559,0.0003164025,0.0008342826,0.0006317782,0.000790227,0.00063970394,0.00062903576,0.0002156305],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008663976,0.00011214499,0.97932786,0.00006524768,0.000032521217,0.00019875586,0.014798961,0.00003250937,0.00020675777,0.00003269624,0.00041154356,0.00469434],"study_design_scores_gemma":[0.000020236128,0.00044750836,0.94180244,0.000085131745,0.00002530305,0.0006997876,0.05548437,0.00017387787,0.000068759706,0.000026215983,0.0011483275,0.000017991846],"about_ca_topic_score_codex":0.016664423,"about_ca_topic_score_gemma":0.017981898,"teacher_disagreement_score":0.016664423,"about_ca_system_score_codex":0.00075328787,"about_ca_system_score_gemma":0.0007598795,"threshold_uncertainty_score":0.033134818},"labels":[],"label_agreement":null}]}